Serina Therapeutics, Inc. SER
1.43 USD +0.05 (+3.62%)
At closeNov 9, 2026, 4:00 PM EST
1.43 0.00 0.00%
After hours · Nov 9, 4:00 PM ET
1.36 Day range 1.54
1.14 52-week range 4.45
- YTD
- -25.13%
- 1 year
- -63.43%
News
globenewswire.com Seres Therapeutics Reports Third Quarter 2026 Financial Results and Announces Plans for Advancing Development of SER-155 To Prevent Immune Checkpoint Inhibitor-Related Enterocolitis (irEC) Prevention approach aims to keep patients on immune checkpoint inhibitor (ICI) therapy and avoid immunosuppressive irEC treatments, representing an additional broad therapeutic opportunity for…
globenewswire.com Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients Peer-reviewed publication reports a 77% relative risk reduction in bloodstream infections and significantly lower systemic antibiotic exposure with SER-155 compared with placebo Translational data…